XOMA Royalty (XOMA) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.60 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 11.36%. A quarter ago, it was expected that this drug developer would post a loss of $0.26 per share when it actually produced a loss of $0.28, delivering a surprise of -7.69%.Over the last four quarters, the company has surp ...